NFKB1 and cancer: Because platelet activation is not only linked to hemostasis, but also has a relevant role in inflammation and metastasis, our present data demonstrating that inhibition of NF-κB interferes with platelet function may have a great impact when these types of drugs are considered for treating cancer and various inflammatory diseases.